Adverum Biotechnologies, Inc.

DB:AVU0 Stock Report

Market Cap: €55.8m

Adverum Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:AVU0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Apr 25Buy€131,031Braden LeonardIndividual50,000€2.62
22 Apr 25Buy€783,990BML Capital Management, LLCCompany300,000€2.61
02 Apr 25Buy€135,471BML Capital Management, LLCCompany34,775€4.03
27 Mar 25Buy€175,025Braden LeonardIndividual37,000€4.81
27 Mar 25Buy€175,025Braden LeonardIndividual37,000€4.81
20 Mar 25Buy€541,509BML Capital Management, LLCCompany117,941€5.17
28 Feb 25Buy€1,383,107BML Capital Management, LLCCompany336,756€4.42
30 Jul 24Buy€567,889BML Capital Management, LLCCompany85,800€6.62
18 Jul 24Buy€1,637,095BML Capital Management, LLCCompany216,264€8.36

Insider Trading Volume

Insider Buying: AVU0 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AVU0?
Owner TypeNumber of SharesOwnership Percentage
Public Companies180,9090.866%
General Public1,355,4966.49%
Individual Insiders2,561,05612.3%
VC/PE Firms2,865,72613.7%
Hedge Funds3,057,52614.6%
Institutions10,869,82752%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
BML Capital Management, LLC
3,057,526€8.2m34.8%6.59%
8.6%
TCG Crossover Management, LLC
1,796,482€4.8m-10.6%0.77%
8.43%
Franklin Resources, Inc.
1,760,056€4.7m0%no data
8.12%
PrIncipia Wealth Advisory, LLC
1,696,815€4.5m27.5%5.03%
6.83%
BlackRock, Inc.
1,426,855€3.8m-3.93%no data
5.35%
Augustus Stern
1,116,628€3.0m0%no data
5.12%
Frazier Life Sciences Management, LP
1,069,244€2.9m0%0.15%
5.03%
Rush Bradford
1,050,000€2.8m0%no data
4.94%
The Vanguard Group, Inc.
1,031,082€2.8m0.33%no data
2.59%
5AM Venture Management, LLC
541,666€1.4m0%0.66%
2.43%
Versant Venture Management, LLC
506,821€1.4m0%0.85%
2.34%
Goldman Sachs Group, Investment Banking and Securities Investments
487,877€1.3m0%no data
2.12%
Geode Capital Management, LLC
442,490€1.2m0.78%no data
1.77%
State Street Global Advisors, Inc.
369,554€987.6k-0.02%no data
1.51%
Pale Fire Capital SE
315,154€842.2k2.2%0.18%
1.49%
Dimensional Fund Advisors LP
311,005€831.1k50.4%no data
1.38%
Soleus Capital Management, L.P.
287,246€767.6k0%0.06%
0.92%
Braden Leonard
191,800€512.6k83%no data
0.87%
Regeneron Pharmaceuticals, Inc.
180,909€483.5k0%no data
0.83%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
172,437€460.8k-0.71%no data
0.73%
Northern Trust Global Investments
152,577€407.7k-1.56%no data
0.71%
Citadel Advisors LLC
149,071€398.4k533%no data
0.62%
Renaissance Technologies LLC
129,605€346.4k250%no data
0.5%
Morgan Stanley, Investment Banking and Brokerage Investments
103,482€276.5k32.2%no data
0.47%
Marshall Wace LLP
98,027€262.0k129%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 23:18
End of Day Share Price 2025/05/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adverum Biotechnologies, Inc. is covered by 20 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gbolahan Amusa BenzChardan Capital Markets, LLC
Daniil GataulinChardan Capital Markets, LLC
Graig SuvannavejhGoldman Sachs